Compare ABCL & BANF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ABCL | BANF |
|---|---|---|
| Founded | 2012 | 1984 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.5B | 3.9B |
| IPO Year | 2020 | 1994 |
| Metric | ABCL | BANF |
|---|---|---|
| Price | $13.27 | $108.08 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 11 | 3 |
| Target Price | $16.70 | ★ $124.33 |
| AVG Volume (30 Days) | ★ 4.4M | 103.9K |
| Earning Date | 11-09-2026 | 10-16-2026 |
| Dividend Yield | N/A | ★ 1.93% |
| EPS Growth | ★ 10.91 | 10.40 |
| EPS | N/A | ★ 3.81 |
| Revenue | ★ $75,128,000.00 | N/A |
| Revenue This Year | N/A | $8.37 |
| Revenue Next Year | $7.91 | $6.35 |
| P/E Ratio | ★ N/A | $27.95 |
| Revenue Growth | ★ 160.56 | N/A |
| 52 Week Low | $2.75 | $101.48 |
| 52 Week High | $14.98 | $128.87 |
| Indicator | ABCL | BANF |
|---|---|---|
| Relative Strength Index (RSI) | 59.09 | 46.98 |
| Support Level | $10.38 | $106.28 |
| Resistance Level | N/A | $116.82 |
| Average True Range (ATR) | 0.77 | 2.03 |
| MACD | 0.05 | -0.05 |
| Stochastic Oscillator | 58.85 | 54.10 |
AbCellera Biologics Inc is a clinical-stage biotechnology company focused on discovering and developing first-in-class antibody medicines for indications with high unmet medical need. It has built a platform for advancing antibody drug programs that the company believes provides it with a competitive advantage in addressing challenging, high-value targets such as complex transmembrane proteins and novel modalities, including multispecifics and antibody-drug conjugates. Organisation's pipeline includes two drug candidates in clinical development, two development candidates in Investigational New Drug (IND/Clinical Trial Application (CTA)-enabling activities, and more than 20 active discovery programs across multiple modalities and indications.
BancFirst Corp is engaged in providing banking services. The company's business unit includes BancFirst metropolitan banks, BancFirst community banks, Pegasus Bank, Worthington, other financial services and executive, operations and support. BancFirst metropolitan banks, BancFirst community banks, Pegasus and Worthington offer traditional banking products such as commercial and retail lending and a full line of deposit accounts. Its Other financial services are specialty product business units including guaranteed small business lending, residential mortgage lending, trust services, securities brokerage, electronic banking, and insurance.